Conatus Pharmaceuticals Inc (CNAT) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 91 transactions totaling $17.2M, demonstrating a bullish sentiment with $17.2M in net insider flow. The most recent transaction on Nov 14, 2018 involved a transaction of 1,861 shares valued at $5.9K.
No significant insider buying has been recorded for CNAT in the recent period.
No significant insider selling has been recorded for CNAT in the recent period.
Based on recent SEC filings, insider sentiment for CNAT is bullish with an Insider Alignment Score of 100/100 and a net flow of $17.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Conatus Pharmaceuticals Inc (CNAT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading CNAT stock, having executed 91 transactions in the past 90 days. The most active insider is Venture Partners Llp Advent (Executive), who has made 5 transactions totaling $2.3M.
Get notified when executives and directors at CNAT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 14, 2018 | L. Ripley Daniel | Executive | Award | 1,861 | $3.15 | $5.9K | |
| Nov 14, 2018 | F. Smith Edward III | Executive | Award | 1,724 | $3.15 | $5.4K | |
| May 14, 2018 | L. Ripley Daniel | Executive | Award | 1,290 | $3.31 | $4.3K | |
| May 14, 2018 | F. Smith Edward III | Executive | Award | 4,690 | $3.31 | $15.5K | |
| May 4, 2018 | J. Mento Steven | Executive | Option Exercise | 60,000 | $0.99 | $59.4K | |
| Feb 27, 2018 | P. Spada Alfred | Executive | Option Exercise | 12,121 | $1.24 | $15.0K | |
| Nov 14, 2017 | L. Ripley Daniel | Executive | Award | 818 | $3.48 | $2.8K | |
| Nov 14, 2017 | F. Smith Edward III | Executive | Award | 4,461 | $3.48 | $15.5K | |
| May 30, 2017 | L. Vandertie Michelle | Executive | Gift | 2,165 | $N/A | $0 | |
| May 12, 2017 | L. Ripley Daniel | Executive | Award | 761 | $1.70 | $1.3K | |
| Jan 9, 2017 | Cashion Charles | Executive | Option Exercise | 42,424 | $0.99 | $42.0K | |
| Dec 28, 2016 | L. Kisner Daniel | Executive | Other | 2,310 | $N/A | $0 | |
| Dec 20, 2016 | J. Mento Steven | Executive | Option Exercise | 5,051 | $0.99 | $5.0K | |
| Dec 20, 2016 | J. Mento Steven | Executive | Option Exercise | 36,363 | $1.24 | $45.1K | |
| Oct 27, 2016 | Harold Van Wart | Executive | Option Exercise | 18,181 | $0.25 | $4.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 15 | $17.2M | 89.3% |
Other(J) | 27 | $1.7M | 9.0% |
Exercise(M) | 8 | $211.1K | 1.1% |
Award(A) | 7 | $50.8K | 0.3% |
Sale(S) | 8 | $32.0K | 0.2% |
Exercise (Options)(X) | 8 | $23.2K | 0.1% |
Gift(G) | 2 | $0 | 0.0% |
Conversion(C) | 16 | $0 | 0.0% |
Insiders at Conatus Pharmaceuticals Inc are accumulating shares at an accelerated pace. With 20 insiders making 91 transactions totaling $17.2M in purchases versus $32.0K in sales, the net buying activity of $17.2M signals strong executive confidence. Venture Partners Llp Advent (Executive) leads the buying activity with $2.3M in transactions across all time.